Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for C9607. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
11
Median % of Medicare
90%
Rate range
$516.97 - $16,525.03
C9607 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $12,150.69* | 95% | -- | 2026 |
| Arizona | $11,515.68 | 90% | -- | 2026 |
| Idaho | $13,841.62 | 108.2% | Not required | 2025 |
| Michigan | $9,795.10 | -- | -- | 2026 |
| Missouri | $16,525.03 | -- | Varies | 2026 |
| Montana | $12,790.20 | 100% | -- | 2026 |
| New Mexico | $7,337.86 | -- | -- | 2026 |
| Oregon | $10,232.16* | 80% | -- | 2026 |
| Rhode Island | $10,568.13 | -- | -- | 2026 |
| Texas | $516.97* | 4% | -- | 2025 |
| Utah | $520.47* | 4.1% | Not required | 2015 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 38 codes from C9047 to C9901 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for C9607?
11 state Medicaid programs publish a fee-for-service rate for C9607 (percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel), ranging from $516.97 in Texas to $16,525.03 in Missouri, with a median of 90% of the national Medicare amount. The full table on this page lists every publishing state's current rate.
Which state pays the most for C9607?
Missouri publishes the highest Medicaid rate for C9607 at $16,525.03. Texas publishes the lowest at $516.97.
Does C9607 require prior authorization under Medicaid?
No publishing state flags C9607 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.